# A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients

> **NCT05442138** · — · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Early Gastric Cancer
- Tumor Organoids

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05442138
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08
- **Primary completion:** 2023-05
- **Final completion:** 2024-06
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05442138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05442138, "A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05442138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*